Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome
Mary E. McQuaid, … , Eric I. Campos, Hugo Wurtele
Mary E. McQuaid, … , Eric I. Campos, Hugo Wurtele
Published May 23, 2022
Citation Information: JCI Insight. 2022;7(10):e155648. https://doi.org/10.1172/jci.insight.155648.
View: Text | PDF
Research Article Cell biology

Hypomorphic GINS3 variants alter DNA replication and cause Meier-Gorlin syndrome

  • Text
  • PDF
Abstract

The eukaryotic CDC45/MCM2-7/GINS (CMG) helicase unwinds the DNA double helix during DNA replication. The GINS subcomplex is required for helicase activity and is, therefore, essential for DNA replication and cell viability. Here, we report the identification of 7 individuals from 5 unrelated families presenting with a Meier-Gorlin syndrome–like (MGS-like) phenotype associated with hypomorphic variants of GINS3, a gene not previously associated with this syndrome. We found that MGS-associated GINS3 variants affecting aspartic acid 24 (D24) compromised cell proliferation and caused accumulation of cells in S phase. These variants shortened the protein half-life, altered key protein interactions at the replisome, and negatively influenced DNA replication fork progression. Yeast expressing MGS-associated variants of PSF3 (the yeast GINS3 ortholog) also displayed impaired growth, S phase progression defects, and decreased Psf3 protein stability. We further showed that mouse embryos homozygous for a D24 variant presented intrauterine growth retardation and did not survive to birth, and that fibroblasts derived from these embryos displayed accelerated cellular senescence. Taken together, our findings implicate GINS3 in the pathogenesis of MGS and support the notion that hypomorphic variants identified in this gene impaired cell and organismal growth by compromising DNA replication.

Authors

Mary E. McQuaid, Kashif Ahmed, Stephanie Tran, Justine Rousseau, Ranad Shaheen, Kristin D. Kernohan, Kyoko E. Yuki, Prerna Grover, Dominique Lévesque, Ema S. Dreseris, Sameen Ahmed, Lucie Dupuis, Jennifer Stimec, Mary Shago, Zuhair N. Al-Hassnan, Roch Tremblay, Philipp G. Maass, Michael D. Wilson, Eyal Grunebaum, Kym M. Boycott, François-Michel Boisvert, Sateesh Maddirevula, Eissa A. Faqeih, Fahad Almanjomi, Zaheer Ullah Khan, Fowzan S. Alkuraya, Philippe M. Campeau, Peter Kannu, Eric I. Campos, Hugo Wurtele

×

Figure 5

DNA replication dynamics are altered in U2OS T-REx Flp-In GINS3-KO cells expressing MGS-associated variants.

Options: View larger image (or click on image) Download as PowerPoint
DNA replication dynamics are altered in U2OS T-REx Flp-In GINS3-KO cells...
(A and B) Western blots showing levels of GINS3cr-FLAG construct and endogenous GINS3 expressed before (A) and after (B) disruption of the endogenous GINS3 gene by CRISPR-Cas9. For each cell line, a minimum of 3 independent protein extractions and 3 independent Western blots were performed; a representative example is shown. (C) Sample flow cytometry plots showing gating strategy for EdU+ cells (left) and bar graph of median EdU signal intensity in EdU+ cells (right). Three cell lines of each genotype were pulsed with EdU for 30 minutes and analyzed. Bars represent mean ± SD, and statistical analyses were performed using 2-tailed t tests. (D) Schematic summary of thymidine analog treatments for the DNA fiber experiment with sample fibers shown below. (E–G) Scatter plots showing median fork speed (E), interorigin distance (F), and fork symmetry (G). Red bars indicate median, and statistical analyses were performed using 2-tailed t tests. The experiment was performed twice; 1 representative replicate is shown. For details on experimental procedures, see Methods. P values were adjusted for multiple comparisons where appropriate (see Methods). *P < 0.05, **P < 0.01, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts